Conditions: Neuralgia, Postherpetic
Keywords: Post-herpetic Neuralgia (PHN) Brivaracetam
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 152
Healthy volunteers: no

Brief summary:
Study will assess efficacy, safety and tolerability of brivaracetam in post-herpetic neuralgia (PHN). Duration of 7 weeks divided into 3 periods with no up-titration, nor down-titration.

Detailed description:

Arms:
arm 1: Matching placebo tablets administered twice a day. arm 2: Brivaracetam 200 mg/day (100 mg administered twice a day). arm 3: Brivaracetam 400 mg/day (200 mg administered twice a day).

Interventions: intervention 1: Placebo intervention 2: Brivaracetam
Intervention descriptions: intervention 1: Daily oral dose of two equal intakes. intervention 2: Daily oral dose of two equal intakes.

Protocol document: